1,4-Bis-but-2-ynyloxy-benzene | 38457-29-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1,4-Bis-but-2-ynyloxy-benzene
• 英文别名: 1,4-Bis[(but-2-yn-1-yl)oxy]benzene；1,4-bis(but-2-ynoxy)benzene
• CAS: 38457-29-3
• 化学式: C₁₄H₁₄O₂
• 分子量: 214.264
• InChiKey: MHKBSQQMZUSIQP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARATION AND USE THEREOF
  申请人：Ivachtchenko Alexandre Vasilievich

  公开号：US20130253008A1

  公开（公告）日：2013-09-26

  The present invention relates to novel azoles, novel antiviral active components of the general formulas 1A and 1B, pharmaceutical composition, antiviral medicament, method for prophylaxis and treatment of viral diseases, particularly caused by hepatitis C viruses (HCV). In general formulas 1A and 1B wherein: solid lines with accompanying dotted lines ( ) represent ordinary bond or double bond, provided that one of them is an ordinary bond, the other one is double bond; X and Y accept various meanings, one of them is—nitrogen, the other—oxygen, sulfur or NH group; R 1 and R 2 —optionally the same radicals selected from 2-(R)- and (S)-substituted N-acyl pyrrolidine derivatives; N-methyl-N-[2-(R) and (S)-substituted 2,2-disubstituted acetamides; methyl[2-(R) and (S)-substituted ((methyl)amino)-(1-oxobutan-2-yl)-2-(R)-] and (S)-iso-propyl)-carbamates. A represents aliphatic C 2 -C 8 biradical; dioxane, cyclo- and bicycloaliphatic, alkyloxyalkyl, alkyloxyalkylenoxyalkyl, alkenyloxyalkyl, alkynyloxyalkyl biradicals and their thioanaloges; aryl and thiophene alkynylcycloalkyl, alkynyldioxane, alkynylaryl, alkylthiophene, alkenylthiophene and alkynylthiophene, alkyloxyaryl, alkenyloxyaryl, alkynyloxyaryl, alkylthioaryl, alkenylthioaryl, alkynylthioaryl, cycloalkylthiophene, aryldioxane and thiophenyldioxane biradicals. B represents: aliphatic C 2 -C 8 radical, including 1, 2 or 3 triple C≡C bonds; aryl and thiophene, alkynylcycloalkyl, alkynyldioxane, alkynylaryl, alkylthiophene, alkenylthiophene and alkynylthiophene, cycloalkylbenzene, 4-cycloalkylbiphenyl, bicycloalkylbenzene, 4-bicycloalkylbiphenyl, cycloalkylthiophene, aryldioxane and thiophenyldioxane radicals.

  本发明涉及新型唑类化合物，通式1A和1B的新型抗病毒活性成分，药物组合物，抗病毒药物，预防和治疗病毒性疾病的方法，特别是由丙型肝炎病毒（HCV）引起的疾病。在通式1A和1B中，其中：实线与伴随虚线（）表示普通键或双键，前提是其中一个是普通键，另一个是双键；X和Y接受各种含义，其中一个是氮，另一个是氧、硫或NH基团；R1和R2—可选地选择自2-(R)-和(S)-取代的N-酰基吡咯烷衍生物；N-甲基-N-[2-(R)和(S)-取代的2,2-二取代乙酰胺；甲基[2-(R)和(S)-取代的((甲基)氨基)-(1-氧代丁酰)-2-(R)-]和(S)-异丙基)-氨基甲酸酯。A代表脂肪族C2-C8双基；二氧六环、环和双环脂肪族、烷氧烷基、烷氧烷氧基烷基、烯烃氧烷基、炔烃氧烷基双基及其硫代物；芳基和噻吩炔基环烷基、炔基二氧六环、炔基芳基、烷基噻吩烯烯基、炔基噻吩、烷氧芳基、烯烃氧芳基、炔烃氧芳基、烷硫芳基、烯硫芳基、炔硫芳基、环烷基噻吩、芳基二氧六环和噻吩二氧六环双基。B代表：脂肪族C2-C8基，包括1、2或3个三重键C≡C键；芳基和噻吩、炔基环烷基、炔基二氧六环、炔基芳基、烷基噻吩、烯烃噻吩和炔基噻吩、环烷基苯、4-环烷基联苯、双环烷基苯、4-双环烷基联苯、环烷基噻吩、芳基二氧六环和噻吩二氧六环基。